ANUH PHARMA
Back to Cashflow Statement
|
ANUH PHARMA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-4.86 Cr | ₹-8.57 Cr | ₹-12 Cr | ₹-19 Cr | ₹-33 Cr |
What is the latest Cash Flow from Financing Activities ratio of ANUH PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-4.86 Cr |
| Mar2024 | ₹-8.57 Cr |
| Mar2023 | ₹-12 Cr |
| Mar2022 | ₹-19 Cr |
| Mar2021 | ₹-33 Cr |
How is Cash Flow from Financing Activities of ANUH PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.86 Cr | Negative | |
| Mar2024 | ₹-8.57 Cr | Negative | |
| Mar2023 | ₹-12 Cr | Negative | |
| Mar2022 | ₹-19 Cr | Negative | |
| Mar2021 | ₹-33 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹741.5 Cr | 3.6% | -8.1% | -25.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 3.6% |
-8.1% |
-25.8% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses